The future of antisense therapy: Combination with anticancer treatments

Oncogene

Volumn 22, Issue 43, 2003, Pages 6579-6588

  Biroccio, Annamaria ^a   Leonetti, Carlo ^a   Zupi, Gabriella ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Antisense; Apoptosis; Combination therapy; Molecular targets; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CAMPTOTHECIN DERIVATIVE; CISPLATIN; CLUSTERIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEFITINIB; GENE EXPRESSION MODULATOR 231; INX 6295; IRINOTECAN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOXANTRONE; OBLIMERSEN; OGX 011; PACLITAXEL; PROLIFERATION ASSOCIATED POLO LIKE KINASE 1; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; PROTEIN MDM2; PROTEIN P53; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL DEATH; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MELANOMA; MOUSE; MULTICENTER STUDY; NONHUMAN; ONCOGENE; ONCOGENE C MYB; ONCOGENE C MYC; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALIA;

EID: 0242456160     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206812     Document Type: Review

References (118)

1. Agrawal S and Zhao Q. (1998). Antisense Nucleic Acid Drug Dev., 8, 135-139.
2. Agrawal S, Kandimalla ER, Yu D, Ball R, Lombardi G, Lucas T, Dexter DL, Hollister BA and Chen SF. (2002). Int. J. Oncol., 21, 65-72.
3. Akie K, Dosaka-Akita H, Murakami A and Kawakami Y. (2000). Antisense Nucleic Acid Drug Dev., 10, 243-249.
4. Alitalo K, Winqvist R, Lin CC, de la Chapelle A, Schwab M and Bishop JM. (1984). Proc. Natl. Acad. Sci. USA, 81, 4534-4538.
5. Baker BF and Monia BP. (1999). Biochim. Biophys. Acta, 1489, 3-18.
6. Balaji KC, Koul H, Mitra S, Maramag C, Reddy P, Menon M, Malhotra RK and Laxmanan S. (1997). Urology, 50, 1007-1015.
7. Biroccio A, Amodei S, Benassi B, Scarsella M, Cianciulli A, Mottolese M, Del Bufalo D, Leonetti C and Zupi G. (2002b). Oncogene, 21, 3011-3019.
8. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D and Zupi G. (2001b). Mol. Pharmacol., 60, 174-182.
9. Biroccio A, Benassi B, D'Agnano I, D'Angelo C, Buglioni S, Mottolese M, Ricciotti A, Citro G, Cosimelli M, Ramsay RG, Calabretta B and Zupi G. (2001a). Am. J. Pathol., 158, 1289-1299.
10. Biroccio A, Benassi B, Filomeni G, Amodei S, Marchini S, Chiorino G, Rotilio G, Zupi G and Ciriolo MR. (2002a). J. Biol. Chem., 277, 43763-43770.
11. Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G and Del Bufalo D. (2000). FASEB J., 14, 652-660.
12. Biroccio A, Gabellini C, Amodei S, Benassi B, Del Bufalo D, Elli R, Antonelli A, D'Incalci M and Zupi G. (2003). Mol. Pharmacol., 63, 632-638.
13. Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF and Monia BP. (1997). Antisense Nucleic Acid Drug Dev., 7, 461-471.
14. Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Ratajczak M, Beran M and Gewirtz AM. (1991). Proc. Natl. Acad. Sci. USA, 88, 2351-2355.
15. Carroll JS, Swarbrick A, Musgrove EA and Sutherland RL. (2002). Cancer Res., 62, 3126-3131.
16. Chao DT and Korsmeyer SJ. (1998). Annu. Rev. Immunol., 16, 395-419.
17. Chi KC, Wallis AE, Lee CH, De Menezes DL, Sartor J, Dragowska WH and Mayer LD. (2000). Breast Cancer Res. Treat., 63, 199-212.
18. Cho YS and Cho-Chung YS. (2003). Clin. Cancer Res., 9, 1171-1178.
19. Cho-Chung YS. (1997). Proc. Assoc. Am. Physicians, 109, 23-32.
20. Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B and Zupi G. (1998). Cancer Res., 58, 283-289.
21. Cleary ML, Smith SD and Sklar J. (1986). Cell, 47, 19-28.
22. Cotter FE. (1997). Hematol. Oncol., 15, 3-11.
23. Crooke ST. (1999). Biochim. Biophys. Acta, 1489, 31-44.
24. Dang CV. (1999). Mol. Cell Biol., 19, 1-11.
25. Del Bufalo D, Cucco C, Leonetti C, Citro G, D'Agnano I, Benassi M, Geiser T, Zon G, Calabretta B and Zupi G. (1996). Br. J. Cancer, 74, 387-393.
26. Ebinuma H, Saito H, Kosuga M, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Okuyama T and Ishii H. (2001). J. Cell. Physiol. 188, 56-66.
27. Elez R, Piiper A, Kronenberger B, Kock M, Brendel M, Hermann E, Pliquett U, Neumann E and Zeuzem S. (2003). Oncogene, 22, 69-80.
28. Fennewald SM and Rando RF. (1995). J. Biol. Chem., 270, 21718-22121.
29. Fernandez A, Udagawa T, Schwesinger C, Beecken W, Achilles-Gerte E, McDonnell T and D'Amato R. (2001). J. Natl. Cancer Inst., 93, 208-213.
30. Funato T, Satou J, Kozawa K, Fujimaki S, Miura T and Kaku M. (2001). Oncol. Rep., 8, 807-810.
31. Gautschi O, Tschopp S, Olie RA, Leech SH, Simoes-Wust AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA and Zangemeister-Wittke U. (2001). J. Natl. Cancer Inst., 93, 463-471.
32. Gelmon K, Batist G, Chi K, Sandor V, Webb M, D'Aloisio S, Burge C, Saltman D, Miller W and Goldie J. (2001). Proceedings of AACR-NCI-Eort, Targets and Therapeutics, Miami Beach, 29 October-2 November, Abstract 801.
33. Gleave ME, Miayake H, Goldie J, Nelson C and Tolcher A. (1999). Urology, 54 (Suppl.), 36-46.
34. Griffin CA and Baylin SB. (1985). Cancer Res., 45, 272-275.
35. Grover R and Wilson GD. (1996). Eur. J. Surg. Oncol., 22, 347-349.
36. Guvakova MA, Yakubov LA, Vlodavsky I, Tonkinson JL and Stein CA. (1995). J. Biol. Chem., 270, 2620-2627.
37. Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP, Wolff K, Pehamberger H and Jansen B. (2002). Int. J. Cancer, 99, 29-34.
38. Hijiya N, Zhang J, Ratajczak MZ, Kant JA, DeRiel K, Herlyn M, Zon G and Gewirtz AM. (1994). Proc. Natl. Acad. Sci. USA, 91, 4499-4503.
39. Holt JT, Redner RL and Nienhuis AW. (1988). Mol. Cell. Biol., 8, 963-973.
40. Huang Y, Snyder R, Kligshteyn M and Wickstrom E. (1995). Mol. Med., 6, 647-658.
41. Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G and Del Bufalo D. (2002). FASEB J., 16, 1453-1455.
42. Itano Y, Ito A, Uehara T and Nomura Y. (1996). J. Neurochem., 67, 131-137.
43. Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van Elsas A, Muller M, Wolff K, Eichler HG and Pehamberger H. (1998). Nat. Med., 4, 232-234.
44. Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K and Pehamberger H. (2000). Lancet, 356, 1728-1733.
45. Janssen JW, Vernole P, de Boer PA, Oosterhuis JW and Collard JG. (1986). Cytogenet. Cell Genet., 41, 129-135.
46. Jiang Z, Zheng X and Rich KM. (2003). J. Neurochem., 84, 273-281.
47. Kang Y, Cortina R and Perry RR. (1996). J. Natl. Cancer Inst., 88, 279-284.
48. Klasa RJ, Bally MB, Ng R, Goldie JH, Gascoyne RD and Wong FM. (2000). Clin. Cancer Res., 6, 2492-2500.
49. Knapp DC, Mata JE, Reddy MT, Devi GR and Iversen PL. (2003). Anticancer Drugs, 14, 39-47.
50. Koller E, Gaarde WA and Monia BP. (2000). Trends Pharmacol. Sci., 21, 142-148.
51. Konopleva M, Tari AM, Estrov Z, Harris D, Xie Z, Zhao S, Lopez-Berestein G and Andreeff M. (2000). Blood, 95, 3929-3938.
52. Lebedeva I, Rando R, Ojwang J, Cossum P and Stein CA. (2000). Cancer Res., 60, 6052-6060.
53. Leech SH, Olie RA, Gautschi O, Simoes-Wust AP, Tschopp S, Haner R, Hall J, Stahel RA and Zangemeister-Wittke U. (2000). Int. J. Cancer, 86, 570-576.
54. Leonetti C, Biroccio A, Benassi B, Stringaro A, Stoppacciaro A, Semple SC and Zupi G. (2001). Cancer Gene Ther., 8, 459-468.
55. Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D and Zupi G. (1999). Clin. Cancer Res., 5, 2588-2595.
56. Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro GC and Zupi G. (1996). J. Natl. Cancer Inst., 88, 419-429.
57. Liu Q and Gazitt Y. (2003). Blood, 101, 4105-4114.
58. Luger SM, O'Brien SG, Ratajczak J, Ratajczak MZ, Mick R, Stadtmauer EA, Nowell PC, Goldman JM and Gewirtz AM. (2002). Blood, 99, 1150-1158.
59. Mercatante DR, Mohler JL and Kole R. (2002). J. Biol. Chem., 277, 49374-49382.
60. Miayake H, Chi KN and Gleave ME. (2000d). Clin. Cancer Res., 6, 1655-1663.
61. Miayake H, Hara I, Kamidono S and Gleave ME. (2001). Clin. Cancer Res., 7, 4245-4252.
62. Miayake H, Monia BP and Gleave ME. (2000b). Int. J. Cancer, 86, 855-862.
63. Miayake H, Nelson C, Rennie PS and Gleave ME. (2000c). Cancer Res., 60, 2547-2554.
64. Miayake H, Tolcher A and Gleave ME. (2000a). J. Natl. Cancer Inst., 92, 34-41.
65. Milella M, Estrov Z, Kornblau SM, Carter BZ, Konopleva M, Tari A, Schober WD, Harris D, Leysath CE, Lopez-Berestein G, Huang Z and Andreeff M. (2002). Blood, 99, 3461-3464.
66. Miller P. (1992). Antisense RNA and DNA Murrey JAH (ed). Wiley-Liss: New York, pp. 241-253.
67. Miller PS and Ts'o PO. (1987). Anticancer Drug Des., 2, 117-128.
68. Olie RA, Hafner C, Kuttel R, Sigrist B, Willers J, Dummer R, Hall J, Stahel RA and Zangemeister-Wittke U. (2002). J. Invest. Dermatol., 118, 505-512.
69. Pakunlu RI, Cook TJ and Minko T. (2003). Pharmacol Res., 20, 351-359.
70. Perez JR, Li Y, Stein CA, Majumder S, van Oorschot A and Narayanan R. (1994). Proc. Natl. Acad. Sci. USA, 91, 5957-5961.
71. Ramsay RG, Barton AL and Gonda TJ. (2003). Expert Opin. Ther. Targets, 7, 235-248.
72. Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G and Gewirtz AM. (1992). Proc. Natl. Acad. Sci. USA, 89, 11823-11827.
73. Reed JC. (1994). J. Cell. Biol., 124, 1-6.
74. Reed JC. (1995). Curr. Opin. Oncol., 7, 541-546.
75. Reed JC. (1999). J. Clin. Oncol., 17, 2941-2953.
76. Simoes-Wust AP, Olie RA, Gautschi O, Leech SH, Haner R, Hall J, Fabbro D, Stahel RA and Zangemeister-Wittke U. (2000). Int. J. Cancer, 87, 582-590.
77. Simoes-Wust AP, Schurpf T, Hall J, Stahel RA and Zangemeister-Wittke U. (2002). Breast Cancer Res. Treat., 76, 157-166.
78. Skorski T, Nieborowska-Skorska M, Campbell K, Iozzo RV, Zon G, Darzynkiewicz Z and Calabretta B. (1995). J. Exp. Med., 182, 1645-1653.
79. Skorski T, Nieborowska-Skorska M, Wlodarski P, Zon G, Iozzo RV and Calabretta B. (1996). Blood, 88, 1005-1012.
80. Smith JB and Wickstrom E. (1998a). J. Natl. Cancer Inst., 90, 1146-1154.
81. Smith JB and Wickstrom E. (1998b). Adv. Exp. Med. Biol., 451, 17-22.
82. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS and Longo DL. (1998). Mol. Cell. Biol., 18, 3509-3517.
83. Srivastava RK, Srivastava AR, Seth P, Agrawal S and ChoChung YS. (1999). Mol. Cell. Biochem., 195, 25-36.
84. Stec WJ, Zon G, Egan W and Stec B. (1984). J. Am. Chem. Soc., 106, 6077-6080.
85. Steiner MS, Anthony CT, Lu Y and Holt JT. (1998). Hum. Gene Ther., 9, 747-755.
86. Stewart DA, Thomas SD, Mayfield CA and Miller DM. (2001). Nucleic Acids Res., 29, 4052-4061.
87. Stewart DA, Xu X, Thomas SD, Miller DM and Xu X. (2002). Nucleic Acids Res., 30, 2565-2574.
88. Supino R, Perego P, Gatti L, Caserini C, Leonetti C, Colantuono M, Zuco V, Carenini N, Zupi G and Zunino F. (2001). Eur. J. Cancer, 37, 2247-2256.
89. Tanabe K, Kim R, Inoue H, Emi M, Uchida Y and Toge T. (2003). Int. J. Oncol., 22, 875-881.
90. Taylor JK, Zhang QQ, Wyatt JR and Dean NM (1999). Nat. Biotechnol., 17, 1097-1100.
91. Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP and Israel MA. (1987). J. Clin. Invest., 80, 804-811.
92. Thompson MA, Rosenthal MA, Ellis SL, Friend AJ, Zorbas MI, Whitehead RH and Ramsay RG. (1998). Cancer Res., 58, 5168-5175.
93. Tortora G and Ciardiello F. (2000). Ann. Oncol., 11, 777-783.
94. Tortora G, Bianco R, Damiano V, Fontanini G, De Placido S, Bianco AR and Ciardiello F. (2000a). Clin. Cancer Res., 6, 2506-2512.
95. Tortora G, Caputo R, Damiano V, Bianco R, Chen J, Agrawal S, Bianco AR and Ciardiello F. (2000b). Int. J. Cancer, 88, 804-809.
96. Tortora G, Caputo R, Damiano V, Bianco R, Fontanini G, Cuccato S, De Placido S, Bianco AR and Ciardiello F. (2001). Clin. Cancer Res., 7, 2537-2544.
97. Tortora G, Caputo R, Damiano V, Troiani T, Veneziani BM, De Placido S, Bianco AR, Zangemeister-Wittke U and Ciardiello F. (2003). Clin. Cancer Res., 9, 866-871.
98. Tortora G, Damiano V, Bianco C, Baldassarre G, Bianco AR, Lanfrancone L, Pelicci PG and Ciardiello F. (1997). Oncogene, 14, 923-928.
99. Tsujimoto Y, Cossman J, Jaffe E and Croce C. (1985). Science, 228, 1440-1443.
100. Vilenchik M, Raffo AJ, Benimetskaya L, Shames D and Stein CA. (2002). Cancer Res., 62, 2175-2183.
101. Vlassov VV, Balakireva LA and Yakubov LA. (1994). Biochim. Biophys. Acta, 1197, 95-108.
102. Wacheck V, Krepler C, Strommer S, Heere-Ress E, Klem R, Pehamberger H, Eichler HG and Jansen B. (2002). Antisense Nucleic Acid Drug Dev., 12, 359-367.
103. Wang H, Cai Q, Zeng X, Yu D, Agrawal S and Zhang R. (1999). Proc. Natl. Acad. Sci. USA, 96, 13989-13994.
104. Wang H, Hang J, Shi Z, Li M, Yu D, Kandimalla ER, Agrawal S and Zhang R. (2002a). Int. J. Oncol., 21, 73-80.
105. Wang H, Nan L, Yu D, Agrawal S and Zhang R. (2001). Clin. Cancer Res., 7, 3613-3624.
106. Wang H, Nan L, Yu D, Lindsey JR, Agrawal S and Zhang R. (2002b). Mol. Med., 8, 185-199.
107. Wang H, Yu D, Agrawal S and Zhang R. (2003). Prostate, 54, 194-205.
108. Watson PH, Pon RT and Shiu RP. (1991). Cancer Res., 51, 3996-4000.
109. Wickstrom EL, Bacon TA, Gonzalez A, Freeman DL, Lyman GH and Wickstrom E. (1988). Proc. Natl. Acad. Sci. USA, 85, 1028-1032.
110. Wooldridge JE, Ballas Z, Krieg AM and Weiner GJ. (1997). Blood, 89, 2994-2998.
111. Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, Yurchenko LV and Vlassov VV. (1989). Proc. Natl. Acad. Sci. USA, 86, 6454-6458.
112. Yang WL, Iacono L, Tang WM and Chin KV. (1998). Biochemistry, 37, 14175-14180.
113. Yokozaki H, Budillon A, Tortora G, Meissner S, Beaucage SL, Miki K and Cho-Chung YS. (1993). Cancer Res., 53, 868-872.
114. Zangemeister-Wittke U, Leech SH, Olie RA, Simoes-Wust AP, Gautschi O, Luedke GH, Natt F, Haner R, Martin P, Hall J, Nalin CM and Stahel RA. (2000). Clin. Cancer Res., 6, 2547-2555.
115. Zangemeister-Wittke U, Schenker T, Luedke GH and Stahel RA. (1998). Br. J. Cancer, 78, 1035-1042.
116. Zellweger T, Chi K, Miayake H, Adomat H, Kiyama S, Skov K and Gleave ME. (2002). Clin. Cancer Res., 8, 3276-3284.
117. Zellweger T, Miayake H, Cooper S, Chi K, Conklin BS, Monia BP and Gleave ME. (2001b). J. Pharmacol. Exp. Ther., 298, 934-940.
118. Zellweger T, Miayake H, July LV, Akbari M, Kiyama S and Gleave ME. (2001a). Neoplasia, 3, 360-367.